𝔖 Bobbio Scriptorium

✦ LIBER ✦

Evaluation of a New Ambulatory Spirometer for Measuring Forced Expiratory Volume in One Second and Peak Expiratory Flow Rate

✍ Scribed by Johns, David P.; Abramson, Michael; Bowes, Glenn

Book ID: 126171759
Publisher: American Thoracic Society
Year: 1993
Tongue: English
Weight: 605 KB
Volume: 147
Category: Article
ISSN: 1073-449X
DOI: 10.1164/ajrccm/147.5.1245

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of peak expiratory flow rate

Comparison of peak expiratory flow rate and forced expiratory volume in one second in histamine challenge studies in children

✍ Richard L. Henry; Craig M. Mellis; Raymond T. South; S.Jane Simpson 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 244 KB

Evaluation of a hand-held spirometer, th

Evaluation of a hand-held spirometer, the Respiradyne, for the measurement of forced expiratory volume in the first second (FEV1), forced vital capacity (FVC) and peak expiratory flow rate (PEFR)

✍ Susan C. Jenkins; Neil C. Barnes; John Moxham 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 1001 KB

Evaluation of the Ferraris pocket peak f

Evaluation of the Ferraris pocket peak flow meter for the measurement of peak expiratory flow rate (PEFR), and forced expiratory volume in the first second (FEV1)

✍ Nolan, K.M.; Dornelly, S.M.; Hughes, D.T.; Strunin, L. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Risk Factors For Rate of Decline in Forc

Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis

✍ Michael W. Konstan; Wayne J. Morgan; Steven M. Butler; David J. Pasta; Marcia L. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 299 KB

A prospective evaluation of the adequacy

A prospective evaluation of the adequacy of peak inspiratory flow rates and validation of the Turbutester score in asthmatic individuals with “low” peak expiratory flow rates: Implications for dry powder inhalers

✍ Melamed, Julian; Beaucher, Wilfred 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 57 KB

[American Thoracic Society American Thor

[American Thoracic Society American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California - ()] A101. PHARMACOLOGICAL TREATMENT OF COPD: OLD AND NEW - Pearl Therapeutics' Combination LAMA/LABA MDI (GFF-MDI, PT003) Provides A Significant Benefit On Home Peak Expiratory Flow Rate (PEFR) And Reduces The Need For Rescue Albuterol Use Compared To Its Components Administered Alone, Spiriva® Handihaler®, And Foradil® Aerolizer® In A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study In Patients With COPD

✍ Reisner, Colin; Rennard, Stephen I.; Fogarty, Charles; Fischer, Tracy; Rose, Ear 📂 Article 📅 2012 🏛 American Thoracic Society ⚖ 20 KB